Blackwell Kimberly
SEC CIK 1816465 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Dir | 504.8K | $51.4K | $323.6K | 12 | 2021-10-25 | 2024-02-01 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Blackwell Kimberly made no open-market trades at ZNTL in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-05 | 2024-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | CEO, Dir | A - Grant | $0.00 | +250.0K | 504.8K | +98% | $0 |
| D | 2024-02-05 | 2024-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | CEO, Dir | F - Tax | $11.69 | -20.7K | 484.1K | -4% | -$241.5K |
| 2023-11-13 | 2023-11-13 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | CEO, Dir | P - Purchase | $10.29 | +5,000 | 254.8K | +2% | +$51.4K | |
| D | 2023-02-01 | 2023-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | CEO, Dir | A - Grant | $0.00 | +244.8K | 249.8K | +4,896% | $0 |
| D | 2022-01-05 | 2022-01-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | S - Sale+OE | $83.74 | -1,000 | 5,000 | -17% | -$83.7K |
| D | 2022-01-05 | 2022-01-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | M - OptEx | $47.80 | +1,000 | 6,000 | +20% | +$47.8K |
| D | 2021-12-02 | 2021-12-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | M - OptEx | $47.80 | +1,000 | 6,000 | +20% | +$47.8K |
| D | 2021-12-02 | 2021-12-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | S - Sale+OE | $81.84 | -1,000 | 5,000 | -17% | -$81.8K |
| D | 2021-11-02 | 2021-11-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | M - OptEx | $47.80 | +1,000 | 6,000 | +20% | +$47.8K |
| D | 2021-11-02 | 2021-11-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | S - Sale+OE | $80.46 | -1,000 | 5,000 | -17% | -$80.5K |
| D | 2021-10-27 | 2021-10-25 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | M - OptEx | $47.80 | +1,000 | 6,000 | +20% | +$47.8K |
| D | 2021-10-27 | 2021-10-25 | ZNTL | Zentalis Pharmaceuticals, Inc. | Blackwell Kimberly | Dir | S - Sale+OE | $77.59 | -1,000 | 5,000 | -17% | -$77.6K |
Purchase Sale Sale after option exercise All abbreviations